Bio-Rad Labs (BIO) Misses Q3 EPS by 46c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $278.21 -2.48%
Revenue Growth %: -7.0%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Revenue Growth %: -7.0%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.40, $0.46 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $530.6 million versus the consensus estimate of $525.4 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- ESSA Bancorp (ESSA) Tops Q2 EPS by 13c
- Ford (F) earnings top estimates in Q1 amid strength in Pro unit; stock up
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
